Heather Bresch, Mylan CEO, responds to the controversy surround the company's 400-percent increase for its injectable allergy medicine.
In a wide-ranging interview, Heather Bresch, Mylan CEO sits CNBC's Brian Sullivan to discuss the controversy surround the recent 400-percent increase in the EpiPen and her frustration with the health care system.
CNBC's Rick Santelli breaks down the latest numbers on unemployment and durable goods.
Susan Lyne, BBG Ventures president & founder, talks about encouraging more women to enter the field of technology and focus on start-ups and venture capital.
Scott Gottlieb AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss whether regulations will impede innovation in the pharmaceutical industry.
Scott Gottlieb, AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss the controversy surround the price hikes of Mylan's EpiPen and the problems that arise when companies obtain monopolies on certain drugs.
Under pressure, Mylan plans to boost access to its EpiPen Auto-Injector by expanding existing programs for patients who are facing higher costs.
Scott Gottlieb, AEI resident fellow, and Sam Waksal, Kadmon Corporation, discuss how competition impacts drug pricing and whether the FDA is working fast enough to streamline its approval process.
Derrick Pitts, Franklin Institute chief astronomer discusses the discovery of a rocky nearby planet that could be the closest possible home for life outside of this solar system.
CNBC's Meg Tirrell follows the economics of the U.S. pharmaceutical supply chain.
Kansas City Fed President Esther George talks to CNBC's Steve Liesman about the Federal Reserve's framework for monetary policy.
CNBC's Courtney Reagan takes a look at earnings results for Tiffany and Sears.
Jim Paulsen, Wells Capital Management, and Michael Hanson, BofA Merrill Lynch, share their expectation on interest rates ahead of the Fed's summit in Jackson Hole, Wyoming.
CNBC's Meg Tirrell breaks down the cost of Mylan's EpiPen.
We want to take the driver out of the system, says Karl Iagnemma, NuTonomy CEO, discussing today's test run of driverless cars in Singapore and the technology involved to launch the self-driving initiative.
The Fed has not acted yet because some recent economic data have given policymakers pause, Kansas City Fed's Esther George tells CNBC.
The "Squawk Box" news team discusses some of the morning's most provocative headlines, including former Comverse Technology CEO Kobi Alexander pleading guilty to securities fraud, Wilbur Ross' firm pays the SEC a $2.3 million fine, and Amazon may be planning a "click and collect" grocery service.
Mark Grant, Hilltop Securities, shares his thoughts on central bank policies and discusses where he is seeing value in the bond market.
Chip Paucek, 2U CEO, talks about his attempts to attract students to online degrees by joining forces with prestigious universities and reverse the stigma that is sometimes attached to online education.
CNBC's Meg Tirrell reports Mylan Pharmaceuticals is under fire for raising the price of EpiPens more than 400-percent since 2007.
Get the best of CNBC in your inbox
Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.
Becky Quick is co-anchor of "Squawk Box" and also anchor of the nationally syndicated "On the Money."
Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.